rcca-header
Clinical Trials

A Phase 2 Study of the Efficacy and Safety Of ACP-196 in Subjects with Relapsed/ Refractory CLL and Intolerant of Ibrutinib Therapy

Type of Cancer
Leukemia
Site
East Brunswick, Freehold, Howell, Little Silver
Sponsor
Acerta
Protocol Number
ACE-CL-208
To Learn More Call
201-510-0910